Are you Dr. Krause?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8217 Lochinver Ln
Potomac, MD 20854Phone+1 301-922-2592
Summary
- Dr. Philip Krause, MD is an infectious disease specialist in Potomac, Maryland. He is currently licensed to practice medicine in Maryland and Florida.
Education & Training
- Clinical Center at the National Institutes of HealthResidency, Internal Medicine, 1987 - 1990
- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1984 - 1985
- Yale School of MedicineClass of 1984
Certifications & Licensure
- FL State Medical License 1996 - 2026
- MD State Medical License 1987 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 120 citationsRecent Advances in Varicella-Zoster Virus InfectionJeffrey I. Cohen, Philip A. Brunell, Sharon E. Straus, Philip R. Krause
Annals of Internal Medicine. 1999-06-01 - 160 citationsPostlicensure safety surveillance for varicella vaccine.Robert P. Wise, Marcel E. Salive, M. Miles Braun, Gina T. Mootrey, Jane F. Seward
JAMA. 2000-09-13 - 157 citationsPlacebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.Sharon E. Straus, Barbara Savarese, Philip R. Krause, R. G. Kost, J.L Meier
Lancet. 1994-06-11
Press Mentions
- I Don’t Recommend FDA’s Infinity Vaccine Booster StrategyApril 7th, 2023
- New US Monkeypox Vaccine Strategy Could Be Huge Boost for Supply, but Much Is UnknownAugust 11th, 2022
- New US Vaccine Strategy Against Monkeypox Could Be a Huge Boost to Supply, but Much Is UnknownAugust 11th, 2022
- Join now to see all